Strategic Partnerships DSV is actively pursuing and expanding venture-building partnerships with large corporates and research institutions (Coca-Cola, Anglo American, ARIA, Cancer Research UK, MDC, ID Capital, Grantham Foundation). This indicates a strong channel for co-investment, strategic alliances, and joint ventures that sales teams can leverage to position supplementary services or targeted collaborations.

Early-Stage Venture Creation As a deeptech venture creator with a first-principles approach across pharmaceuticals, climate, agriculture and computation, DSV seeks to translate scientific knowledge into scalable ventures. This presents opportunities to offer specialized acceleration, fund-structuring, or technical due diligence services to ecosystem players and partner organizations.

Brain-Targeted Therapeutics Recent coverage about developing approaches to deliver life-changing medicines to the brain signals potential demand for expertise in CNS-targeted projects, translational biology, and infrastructure partnerships that support drug discovery platforms, enabling vendors to offer workflow tools, data services, or collaboration space.

Sustainability Focus Detox Awards and environmental partnerships with Grantham Foundation, ID Capital, and agricultural/cycle-focused initiatives show a priority on toxicity reduction and sustainable solutions in food, agriculture and packaging. This creates openings for environmental tech vendors, risk/compliance tooling, and ecosystem funding services aligned with ESG goals.

Global Ecosystem Access DSV’s network includes Coca-Cola, Anglo American, ARIA, Cancer Research UK and academic/institutional partners, offering a platform for market access, pilot programs, and co-development deals. Sales opportunities exist in providing platform support, market-entry services, regulatory readiness, and enterprise-grade cloud/tech enablement to scale collaborations.